Incidence of a first thromboembolic event in asymptomatic carriers of high-risk antiphospholipid antibody profile: a multicenter prospective study
Top Cited Papers
- 27 October 2011
- journal article
- research article
- Published by American Society of Hematology in Blood
- Vol. 118 (17), 4714-4718
- https://doi.org/10.1182/blood-2011-03-340232
Abstract
Persistent antiphospholipid (aPL) antibodies are occasionally found in subjects without prior history of thromboembolic events (TEs), raising the dilemma of whether to initiate or not a primary thromboprophylaxis. A first TE is considered rare in aPL carriers, but previous studies did not consider the aPL profile nor was the test positivity confirmed in a reference laboratory. In this study, 104 subjects with high-risk aPL profile (positive lupus anticoagulant, anticardiolipin, and anti-β2–glycoprotein I antibodies, triple positivity) confirmed in a reference laboratory, were followed up for a mean of 4.5 years. There were 25 first TEs (5.3% per year): the cumulative incidence after 10 years was 37.1% (95% confidence interval [CI], 19.9%-54.3%). On multivariate analysis, male sex (hazard ratio = 4.4; 95% CI, 1.5-13.1, P = .007) and risk factors for venous thromboembolism (hazard ratio = 3.3; 95% CI, 1.3-8.5, P = .01) were independent predictors for TEs. Aspirin did not significantly affect the incidence of TE. In conclusion, the occurrence of a first TE in carriers of high-risk aPL profile is considerable; it is more frequent among male subjects and in the presence of additional risk factors for venous TE. These data can help in the decision to initiate primary thromboprophylaxis in these subjects.Keywords
This publication has 25 references indexed in Scilit:
- Heart Disease and Stroke Statistics—2011 UpdateCirculation, 2011
- Risk factors for a first thrombotic event in antiphospholipid antibody carriers: a prospective multicentre follow-up studyAnnals Of The Rheumatic Diseases, 2011
- Clinical course of high‐risk patients diagnosed with antiphospholipid syndromeJournal of Thrombosis and Haemostasis, 2010
- Oral PresentationsJournal of Thrombosis and Haemostasis, 2008
- A contribution to the debate on the laboratory criteria that define the antiphospholipid syndromeJournal of Thrombosis and Haemostasis, 2008
- A Comparison of Lupus Anticoagulant–Positive Patients With Clinical Picture of Antiphospholipid Syndrome and Those WithoutArteriosclerosis, Thrombosis, and Vascular Biology, 2007
- Survey of lupus anticoagulant diagnosis by central evaluation of positive plasma samplesJournal of Thrombosis and Haemostasis, 2007
- Anti-β2-glycoprotein I antibodies are associated with pregnancy loss in women with the lupus anticoagulantThrombosis and Haemostasis, 2006
- Antibody profiles for the diagnosis of antiphospholipid syndromeThrombosis and Haemostasis, 2005
- Do antibodies to β2-glycoprotein 1 contribute to the better characterization of the antiphospholipid syndrome?Lupus, 1999